PURPOSE: To evaluate the ability of X-linked inhibitor of apoptosis (XIAP) gene therapy to provide neuroprotection to cells of the outer nuclear layer (ONL) of the retina after retinal detachment. METHODS: Subretinal injections of a recombinant adenoassociated virus (rAAV) encoding either XIAP or green fluorescent protein (GFP; injection control) were performed in the left eye of Brown Norway rats. Two weeks later, retinal detachments were created at the site of viral injection by delivering sodium hyaluronate into the subretinal space. Retinal tissue was harvested at 24 hours after retinal detachment and was analyzed for caspase 3 and 9 activity. Histologic analysis was conducted on samples taken at 3 days and 2 months after detachment to confirm the presence of XIAP or GFP expression and to assess levels of apoptosis and changes in retinal thickness. RESULTS: Caspase assays performed 24 hours after detachment confirmed an expected increase in caspase 3 and 9 activity in the detached regions of GFP-treated retinas, whereas XIAP-treated detached retinas behaved comparably to attached controls. TUNEL analysis of 3-day tissue samples showed fewer apoptotic cells in XIAP-treated detachments than in GFP-treated detachments. At 2 months after the detachment, histology and immunohistochemistry confirmed the preservation of the ONL at sites of XIAP overexpression, whereas the GFP-treated detached retinas had significantly deteriorated. CONCLUSIONS: The results suggest that XIAP confers structural neuroprotection of photoreceptors for at least 2 months after retinal detachment.
PURPOSE: To evaluate the ability of X-linked inhibitor of apoptosis (XIAP) gene therapy to provide neuroprotection to cells of the outer nuclear layer (ONL) of the retina after retinal detachment. METHODS: Subretinal injections of a recombinant adenoassociated virus (rAAV) encoding either XIAP or green fluorescent protein (GFP; injection control) were performed in the left eye of Brown Norway rats. Two weeks later, retinal detachments were created at the site of viral injection by delivering sodium hyaluronate into the subretinal space. Retinal tissue was harvested at 24 hours after retinal detachment and was analyzed for caspase 3 and 9 activity. Histologic analysis was conducted on samples taken at 3 days and 2 months after detachment to confirm the presence of XIAP or GFP expression and to assess levels of apoptosis and changes in retinal thickness. RESULTS: Caspase assays performed 24 hours after detachment confirmed an expected increase in caspase 3 and 9 activity in the detached regions of GFP-treated retinas, whereas XIAP-treated detached retinas behaved comparably to attached controls. TUNEL analysis of 3-day tissue samples showed fewer apoptotic cells in XIAP-treated detachments than in GFP-treated detachments. At 2 months after the detachment, histology and immunohistochemistry confirmed the preservation of the ONL at sites of XIAP overexpression, whereas the GFP-treated detached retinas had significantly deteriorated. CONCLUSIONS: The results suggest that XIAP confers structural neuroprotection of photoreceptors for at least 2 months after retinal detachment.
Authors: Sergei Zolotukhin; Mark Potter; Irene Zolotukhin; Yoshihisa Sakai; Scott Loiler; Thomas J Fraites; Vince A Chiodo; Tina Phillipsberg; Nicholas Muzyczka; William W Hauswirth; Terance R Flotte; Barry J Byrne; Richard O Snyder Journal: Methods Date: 2002-10 Impact factor: 3.608
Authors: Guido Straten; Christian Schmeer; Alexandra Kretz; Ellen Gerhardt; Sebastian Kügler; Jörg B Schulz; Claude Gravel; Mathias Bähr; Stefan Isenmann Journal: Neurobiol Dis Date: 2002-10 Impact factor: 5.996
Authors: Geoffrey P Lewis; David G Charteris; Charanjit S Sethi; William P Leitner; Kenneth A Linberg; Steven K Fisher Journal: Invest Ophthalmol Vis Sci Date: 2002-07 Impact factor: 4.799
Authors: S J Crocker; P Liston; H Anisman; C J Lee; P D Smith; N Earl; C S Thompson; D S Park; R G Korneluk; G S Robertson Journal: Neurobiol Dis Date: 2003-03 Impact factor: 5.996
Authors: O Eberhardt; R V Coelln; S Kugler; J Lindenau; S Rathke-Hartlieb; E Gerhardt; S Haid; S Isenmann; C Gravel; A Srinivasan; M Bahr; M Weller; J Dichgans; J B Schulz Journal: J Neurosci Date: 2000-12-15 Impact factor: 6.167
Authors: Stuart J McKinnon; Donna M Lehman; N Grace Tahzib; Nancy L Ransom; Herbert A Reitsamer; Peter Liston; Eric LaCasse; Qiuhong Li; Robert G Korneluk; William W Hauswirth Journal: Mol Ther Date: 2002-06 Impact factor: 11.454
Authors: David N Zacks; Virve Hänninen; Mina Pantcheva; Eric Ezra; Cynthia Grosskreutz; Joan W Miller Journal: Invest Ophthalmol Vis Sci Date: 2003-03 Impact factor: 4.799
Authors: Dino Petrin; Adam Baker; Stuart G Coupland; Peter Liston; Monica Narang; Karim Damji; Brian Leonard; Vince A Chiodo; Adrian Timmers; William Hauswirth; Robert G Korneluk; Catherine Tsilfidis Journal: Invest Ophthalmol Vis Sci Date: 2003-06 Impact factor: 4.799
Authors: Jingyu Yao; Kecia L Feathers; Hemant Khanna; Debra Thompson; Catherine Tsilfidis; William W Hauswirth; John R Heckenlively; Anand Swaroop; David N Zacks Journal: Invest Ophthalmol Vis Sci Date: 2011-03-01 Impact factor: 4.799
Authors: Mercy Pawar; Boris Busov; Aaruran Chandrasekhar; Jingyu Yao; David N Zacks; Cagri G Besirli Journal: Cell Death Differ Date: 2017-07-14 Impact factor: 15.828
Authors: Sarah J Wassmer; Brian C Leonard; Stuart G Coupland; Adam N Baker; John Hamilton; William W Hauswirth; Catherine Tsilfidis Journal: Hum Gene Ther Date: 2017-03-23 Impact factor: 5.695
Authors: Cagri G Besirli; Nicholas D Chinskey; Qiong-Duan Zheng; David N Zacks Journal: Invest Ophthalmol Vis Sci Date: 2009-10-22 Impact factor: 4.799
Authors: Richard J Blanch; Zubair Ahmed; Adam R Thompson; Nsikan Akpan; David R J Snead; Martin Berry; Carol M Troy; Robert A H Scott; Ann Logan Journal: Invest Ophthalmol Vis Sci Date: 2014-09-04 Impact factor: 4.799